{"id":"W4403250931","doi":"10.2139/ssrn.4969633","title":"A First-in-Human Phase 1/2 Dose-Escalation Study of Mak683 (Eed Inhibitor) in Patients with Advanced Malignancies","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"De-escalation; Medicine; Maximum tolerated dose; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007245501,0.0004794339,0.0009323938,0.0008102914,0.00007083012,0.00003155307,0.0002334927,0.0001962072,0.00002018134],"category_scores_gemma":[0.00003731154,0.000395191,0.0001331185,0.0005146493,0.0000786692,0.0001459164,0.0002006276,0.004669053,0.000002762746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003618534,"about_ca_system_score_gemma":0.00232091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001891733,"about_ca_topic_score_gemma":0.005480786,"domain_scores_codex":[0.9960014,0.0001017229,0.0009893122,0.0005938741,0.0007684829,0.001545169],"domain_scores_gemma":[0.9985788,0.00003436334,0.0005886538,0.0004377945,0.0002651125,0.0000952483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03615585,0.0260989,0.7246969,0.002421293,0.003263969,0.0003913427,0.02039493,0.02467013,0.003314966,0.003410876,0.00001261574,0.1551683],"study_design_scores_gemma":[0.1402387,0.04001753,0.6426139,0.01384585,0.001086295,0.0002701389,0.01775181,0.0003839767,0.0007820781,0.1410655,0.0001758051,0.001768402],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938201,0.003575324,0.0001773755,0.0001987936,0.0002652415,0.00184789,0.00001353676,0.00004524305,0.00005649246],"genre_scores_gemma":[0.998946,0.0002753043,0.000141589,0.00001774607,0.0002036948,0.0001117524,0.00003709651,0.000104932,0.0001619189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1533999,"threshold_uncertainty_score":0.99985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008059983410896046,"score_gpt":0.2883609029510119,"score_spread":0.2803009195401159,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}